Pharma industry vet to lead AGC’s Boulder plant
BOULDER — Pharmaceutical company AGC Biologics Inc. has tapped industry veteran Regina Choi-Rivera to serve as general manager of its Boulder manufacturing facility.
The company, which also operates a plant in Longmont, acquired the shuttered AstraZeneca PLC plant in Boulder in 2020 and has built out a contract drug manufacturing operation there.
Choi-Rivera has held leadership roles with Samsung Biologics Co. and Janssen Pharmaceuticals, according to an AGC news release.
“I am delighted to join AGC Biologics at such an exciting time of growth for the company and at such a transformational time for our industry,” Choi-Rivera said in the release. “The…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
OnKure Inc., a Boulder precision oncology company, and California-based Reneo Pharmaceuticals Inc. have completed a…
-
Mosaic Biosciences Inc., a Boulder drug-discovery company that provides protein and antibody therapeutics research to…